Views | |
---|---|
Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature | 46 |
March 2023 | April 2023 | May 2023 | June 2023 | July 2023 | August 2023 | September 2023 | |
---|---|---|---|---|---|---|---|
Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature | 12 | 16 | 6 | 5 | 2 | 3 | 2 |
Views | |
---|---|
Grau_erait_comp.pdf | 34 |
Views | |
---|---|
United States | 16 |
Germany | 7 |
Spain | 7 |
South Korea | 2 |
Turkey | 2 |
Ecuador | 1 |
France | 1 |
Ireland | 1 |
Israel | 1 |
Iran | 1 |
Views | |
---|---|
San Ramon | 5 |
Barcelona | 4 |
Redwood City | 2 |
Valencia | 2 |
Ala | 1 |
Amstelveen | 1 |
Ann Arbor | 1 |
Ashburn | 1 |
Durham | 1 |
Lima | 1 |